OneSpaWorld Q1 revenue $211.2M (+16% YoY); raises FY2024 guidance; approves $50M buyback

ONESPAWORLD HOLDINGS Ltd

2024-Q1 EPS reported $0.21 revenue$211,226,000

Q1 total revenue $211.2M (+16% YoY), operating income $17.0M (+52%), adjusted EBITDA $25.3M (+31%).
FY2024 revenue guidance raised to $860-$880M (from $850-$870M); Adj. EBITDA guidance raised to $95-$105M (from $90-$100M).
Board approved $50M share repurchase program; company repurchased 606,386 shares for $7.7M in Q1.
Ended Q1 with 193 ships (avg 188); new exclusive deal with Royal Caribbean/Celebrity Cruises for 40 ships; added Aroya Cruises.
Cash $66.6M; repaid $20M on term loan; received $51.7M net from warrant conversion; private equity overhang eliminated.

item 2.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ONESPAWORLD HOLDINGS Ltd reported first quarter ended March 31, 2024 results: revenue $211.2 million. Guidance raised.

Period: first quarter ended March 31, 2024
Revenue: $211.2 million
Guidance: raised
Result: reported results

Exact text from the filing

99.1 OneSpaWorld Reports Record First Quarter Fiscal 2024 Results and Increases Fiscal Year Guidance Board Authorizes $50 Million Share Repurchase Program Total Revenues of $211.2 Million, Income from Operations of $17.0 Million and Adjusted EBITDA of $25.3 Million Increases Fiscal 2024 Revenues Guidance to $860 - $880 Million from $850 - $870 Million Increases

View on SEC.gov

1436 earnings releases filed in the last 30 days. Browse all earnings releases →

ONESPAWORLD HOLDINGS Ltd filing history →

Source: SEC EDGAR

accession 0000950170-24-050882

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.